OPPENHEIMER & CO INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$89,000
-84.9%
11,300
-76.3%
0.00%
-81.2%
Q2 2015$589,000
-45.8%
47,600
-47.9%
0.02%
-46.7%
Q1 2015$1,086,000
+3.5%
91,400
-1.5%
0.03%0.0%
Q4 2014$1,049,000
+61.4%
92,800
+25.2%
0.03%
+57.9%
Q3 2014$650,000
+18.6%
74,100
-1.3%
0.02%
+18.8%
Q2 2014$548,000
-2.3%
75,100
-32.5%
0.02%
-5.9%
Q1 2014$561,000111,2400.02%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders